Analysis of the Effect of Intravitreal Bevacizumab Injection on Diabetic Macular Edema after Cataract Surgery
- 30 June 2009
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 116 (6), 1151-1157
- https://doi.org/10.1016/j.ophtha.2009.01.014
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular EdemaOphthalmology, 2008
- Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edemaJournal of Cataract & Refractive Surgery, 2007
- A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular EdemaOphthalmology, 2007
- Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot StudyOphthalmology, 2007
- Comparison of the Modified Early Treatment Diabetic Retinopathy Study and Mild Macular Grid Laser Photocoagulation Strategies for Diabetic Macular EdemaAmerican Journal of Ophthalmology, 2007
- Vitreous Levels of Pigment Epithelium–Derived Factor and Vascular Endothelial Growth Factor Are Related to Diabetic Macular EdemaOphthalmology, 2006
- Detection of Early Diabetic Change with Optical Coherence Tomography in Type 2 Diabetes Mellitus Patients without RetinopathyOphthalmologica, 2005
- Optical Coherence Tomographic Assessment of Diabetic Macular Edema: Comparison with Fluorescein Angiographic and Clinical FindingsOphthalmologica, 2005
- Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: Three-monthefficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trialOphthalmology, 2004
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004